UK markets open in 7 hours 56 minutes

Apyx Medical Corporation (APYX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.4000-0.0300 (-2.10%)
At close: 04:00PM EDT
1.4391 +0.04 (+2.79%)
After hours: 05:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 49.19M
Enterprise value 44.04M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.94
Price/book (mrq)1.84
Enterprise value/revenue 0.84
Enterprise value/EBITDA -2.43

Trading information

Stock price history

Beta (5Y monthly) 1.12
52-week change 3-60.28%
S&P500 52-week change 323.10%
52-week high 37.9700
52-week low 31.2100
50-day moving average 31.6493
200-day moving average 32.7917

Share statistics

Avg vol (3-month) 3157.18k
Avg vol (10-day) 379.29k
Shares outstanding 534.64M
Implied shares outstanding 634.64M
Float 824.98M
% held by insiders 117.92%
% held by institutions 148.01%
Shares short (15 Apr 2024) 4371.13k
Short ratio (15 Apr 2024) 41.32
Short % of float (15 Apr 2024) 41.11%
Short % of shares outstanding (15 Apr 2024) 41.07%
Shares short (prior month 15 Mar 2024) 41.57M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -35.75%
Operating margin (ttm)-39.39%

Management effectiveness

Return on assets (ttm)-18.80%
Return on equity (ttm)-58.25%

Income statement

Revenue (ttm)52.35M
Revenue per share (ttm)1.51
Quarterly revenue growth (yoy)16.30%
Gross profit (ttm)N/A
EBITDA -19.01M
Net income avi to common (ttm)-18.71M
Diluted EPS (ttm)-0.5400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)43.65M
Total cash per share (mrq)1.26
Total debt (mrq)38.5M
Total debt/equity (mrq)143.01%
Current ratio (mrq)5.52
Book value per share (mrq)0.77

Cash flow statement

Operating cash flow (ttm)-5.25M
Levered free cash flow (ttm)3.37M